Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a pandemic. As immunity to endemic human coronaviruses (i.e. NL63 or OC43) wanes leading to re-infection, it was unknown if SARS-CoV-2 immunity would also decline permitting repeat infections. Recent case reports confirm previou...

Full description

Bibliographic Details
Main Authors: C. J. Field, T. A. Heinly, D. R. Patel, D. G. Sim, E. Luley, S. L. Gupta, T. H. Vanderford, J. Wrammert, T. C. Sutton
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2058419
_version_ 1818273115890778112
author C. J. Field
T. A. Heinly
D. R. Patel
D. G. Sim
E. Luley
S. L. Gupta
T. H. Vanderford
J. Wrammert
T. C. Sutton
author_facet C. J. Field
T. A. Heinly
D. R. Patel
D. G. Sim
E. Luley
S. L. Gupta
T. H. Vanderford
J. Wrammert
T. C. Sutton
author_sort C. J. Field
collection DOAJ
description Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a pandemic. As immunity to endemic human coronaviruses (i.e. NL63 or OC43) wanes leading to re-infection, it was unknown if SARS-CoV-2 immunity would also decline permitting repeat infections. Recent case reports confirm previously infected individuals can become re-infected; however, re-infection may be due to heterogeneity in the initial infection or the host immune response, or may be the result of infection with a variant strain that escapes pre-existing immunity. To control these variables, we utilized the Syrian hamster model to evaluate the duration of immunity and susceptibility to re-infection with SARS-CoV-2. Hamsters were given a primary mock or SARS-CoV-2 infection (culture media or 105 TCID50 USA/WA1/2020 isolate, respectively). Mock and SARS-CoV-2 infected hamsters were then given a secondary SARS-CoV-2 infection at 1, 2, 4, or 6 months post-primary infection (n = 14/time point/group). After the primary SARS-CoV-2 infection, hamsters developed anti-spike protein IgG, IgA, and neutralizing antibodies, and these antibodies were maintained for at least 6 months. Upon secondary SARS-CoV-2 challenge, previously SARS-CoV-2 infected animals were protected from weight loss, while all previously mock-infected animals became infected and lost weight. Importantly, despite having high titres of antibodies, one SARS-CoV-2 infected animal re-challenged at 4 months had a breakthrough infection with replicating virus in the upper and lower respiratory tract. These studies demonstrate immunity to SARS-CoV-2 is maintained for 6 months; however, protection may be incomplete and, even in the presence of high antibody titres, previously infected hosts may become re-infected.
first_indexed 2024-12-12T21:52:50Z
format Article
id doaj.art-b3c0b2ae07854c4d965d495dbe7903d2
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-12-12T21:52:50Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-b3c0b2ae07854c4d965d495dbe7903d22022-12-22T00:10:44ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512022-12-011111103111410.1080/22221751.2022.2058419Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamstersC. J. Field0T. A. Heinly1D. R. Patel2D. G. Sim3E. Luley4S. L. Gupta5T. H. Vanderford6J. Wrammert7T. C. Sutton8Department of Veterinary and Biomedical Science, The Pennsylvania State University, University Park, PA, USADepartment of Veterinary and Biomedical Science, The Pennsylvania State University, University Park, PA, USADepartment of Veterinary and Biomedical Science, The Pennsylvania State University, University Park, PA, USAThe Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA, USAAnimal Diagnostic Lab, The Pennsylvania State University, University Park, PA, USADepartment of Pediatrics, Division of Infectious Disease, School of Medicine, Emory University, Atlanta, GA, USADivision of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USAEmory-UGA Center of Excellence of Influenza Research and Surveillance (CEIRS), University Park, PA, USADepartment of Veterinary and Biomedical Science, The Pennsylvania State University, University Park, PA, USASevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a pandemic. As immunity to endemic human coronaviruses (i.e. NL63 or OC43) wanes leading to re-infection, it was unknown if SARS-CoV-2 immunity would also decline permitting repeat infections. Recent case reports confirm previously infected individuals can become re-infected; however, re-infection may be due to heterogeneity in the initial infection or the host immune response, or may be the result of infection with a variant strain that escapes pre-existing immunity. To control these variables, we utilized the Syrian hamster model to evaluate the duration of immunity and susceptibility to re-infection with SARS-CoV-2. Hamsters were given a primary mock or SARS-CoV-2 infection (culture media or 105 TCID50 USA/WA1/2020 isolate, respectively). Mock and SARS-CoV-2 infected hamsters were then given a secondary SARS-CoV-2 infection at 1, 2, 4, or 6 months post-primary infection (n = 14/time point/group). After the primary SARS-CoV-2 infection, hamsters developed anti-spike protein IgG, IgA, and neutralizing antibodies, and these antibodies were maintained for at least 6 months. Upon secondary SARS-CoV-2 challenge, previously SARS-CoV-2 infected animals were protected from weight loss, while all previously mock-infected animals became infected and lost weight. Importantly, despite having high titres of antibodies, one SARS-CoV-2 infected animal re-challenged at 4 months had a breakthrough infection with replicating virus in the upper and lower respiratory tract. These studies demonstrate immunity to SARS-CoV-2 is maintained for 6 months; however, protection may be incomplete and, even in the presence of high antibody titres, previously infected hosts may become re-infected.https://www.tandfonline.com/doi/10.1080/22221751.2022.2058419SARS-CoV-2antibodiesre-infectionhamsterimmunity
spellingShingle C. J. Field
T. A. Heinly
D. R. Patel
D. G. Sim
E. Luley
S. L. Gupta
T. H. Vanderford
J. Wrammert
T. C. Sutton
Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
Emerging Microbes and Infections
SARS-CoV-2
antibodies
re-infection
hamster
immunity
title Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
title_full Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
title_fullStr Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
title_full_unstemmed Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
title_short Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
title_sort immune durability and protection against sars cov 2 re infection in syrian hamsters
topic SARS-CoV-2
antibodies
re-infection
hamster
immunity
url https://www.tandfonline.com/doi/10.1080/22221751.2022.2058419
work_keys_str_mv AT cjfield immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT taheinly immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT drpatel immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT dgsim immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT eluley immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT slgupta immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT thvanderford immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT jwrammert immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters
AT tcsutton immunedurabilityandprotectionagainstsarscov2reinfectioninsyrianhamsters